Qiagen N.V. (VIE:QGE4)

Market Cap	9.05B -8.9%
Revenue (ttm)	1.76B +5.3%
Net Income	345.50M +336.2%
EPS	1.65 +331.3%
Shares Out	n/a
PE Ratio	26.19
Forward PE	19.99
Dividend	2.18 (4.86%)
Ex-Dividend Date	Jan 8, 2026

Volume	n/a
Average Volume	0
Open	44.75
Previous Close	44.92
Day's Range	44.63 - 44.87
52-Week Range	37.24 - 47.50
Beta	n/a
RSI	53.20
Earnings Date	Feb 4, 2026

About Qiagen

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and...

• Industry: Laboratory Analytical Instruments
• Founded: 1984
• Employees: 5,700
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: QGE4

Financial Performance

In 2024, Qiagen's revenue was $1.98 billion, an increase of 0.66% compared to the previous year's $1.97 billion. Earnings were $83.59 million, a decrease of -75.51%.

Financial numbers in USD